Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 7 Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 2 Advanced Solid Tumors 2 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non Small Lung Cancer 1 Mesothelioma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 KRAS p, G12c Mutated /Advanced Metastatic NSCLC 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Brain Neoplasms 1 Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation 1 Advanced Solid Tumor 1

Interventions

Radiosurgery 23 Temozolomide 14 Magnetic Resonance Spectroscopy 14 pembrolizumab 11 Bevacizumab 11 Nivolumab 10 Ipilimumab 8 Specimen Handling 6 Memantine 6 abemaciclib 5 Radiotherapy 5 Mental Status and Dementia Tests 5 Blood Specimen Collection 5 Radiation 4 entrectinib 3 Surveys and Questionnaires 3 Sodium Chloride 3 Saline Solution 3 Receptors, Interleukin-8B 3 Proton Therapy 3 Lomustine 3 trastuzumab deruxtecan 2 trametinib 2 pertuzumab 2 osimertinib 2 lenvatinib 2 fluciclovine F-18 2 contrast agent BR1 2 atezolizumab 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × sotorasib × 90 days × Clear all

NCT06807619 2026-05-22

A Study of Sotorasib in People With Brain Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡